Gourab Bhattacharjee

Title: Innovations of Gourab Bhattacharjee

Introduction

Gourab Bhattacharjee is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biomedical research, particularly in the modulation of kallikrein expression. With a total of 3 patents to his name, his work focuses on addressing critical health conditions.

Latest Patents

Gourab Bhattacharjee's latest patents include innovative methods for modulating kallikrein (KLKB1) expression. One of his patents discloses methods for decreasing kallikrein to treat or prevent thromboembolic conditions. This includes conditions such as thrombosis, embolism, and thromboembolism, which can lead to serious health issues like deep vein thrombosis, pulmonary embolism, myocardial infarction, and stroke. Another patent focuses on methods for inhibiting kallikrein to treat or prevent inflammatory conditions, specifically targeting hereditary angioedema (HAE). These methods can also serve as prophylactic treatments for individuals at risk of developing such conditions.

Career Highlights

Throughout his career, Gourab has worked with prominent companies in the pharmaceutical industry, including Ionis Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. His expertise in the field has allowed him to contribute to groundbreaking research and development.

Collaborations

Gourab has collaborated with esteemed colleagues such as Alexey Revenko and Robert A MacLeod. These partnerships have further enhanced his research and innovation efforts.

Conclusion

Gourab Bhattacharjee's work in modulating kallikrein expression showcases his commitment to advancing medical science. His patents reflect a dedication to improving health outcomes for individuals at risk of serious conditions. His contributions to the field are invaluable and continue to inspire future innovations.